Breaking News Instant updates and real-time market news.

FGEN

FibroGen

$48.79 /

+ (+0.00%)

, AKBA

Akebia

$3.11 /

+ (+0.00%)

09:40
10/12/20
10/12
09:40
10/12/20
09:40

Unusually active option classes on open October 12th

Unusual total active option classes on open include: FibroGen (FGEN), Akebia (AKBA), DPHC (DPHC), Jumia Technologies (JMIA), Lyft (LYFT), JinkoSolar (JKS), Workhorse Group (WKHS), Eli Lilly (LLY), Aphria (APHA), and Ford (F).

FGEN

FibroGen

$48.79 /

+ (+0.00%)

AKBA

Akebia

$3.11 /

+ (+0.00%)

DPHC

DiamondPeak Holdings

$23.03 /

+ (+0.00%)

JMIA

Jumia Technologies

$10.36 /

+ (+0.00%)

LYFT

Lyft

$27.81 /

+ (+0.00%)

JKS

JinkoSolar

$62.91 /

+ (+0.00%)

WKHS

Workhorse Group

$26.77 /

+ (+0.00%)

LLY

Eli Lilly

$156.83 /

+ (+0.00%)

APHA

Aphria

$5.75 /

+ (+0.00%)

F

Ford

$7.25 /

+ (+0.00%)

  • 15

    Oct

  • 23

    Oct

  • 27

    Oct

  • 02

    Nov

  • 20

    Dec

  • 12

    May

FGEN FibroGen
$48.79 /

+ (+0.00%)

09/04/20 Stifel
FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel
07/10/20 Stifel
FibroGen transferred with Buy rating, $71 target at Stifel
05/06/20 RBC Capital
Akebia price target raised to $12 from $8 at RBC Capital
05/05/20 Piper Sandler
Piper Sandler remains a buyer of Akebia following Phase 3 INNO2VATE data
AKBA Akebia
$3.11 /

+ (+0.00%)

09/04/20 RBC Capital
Akebia price target lowered to $5 from $12 at RBC Capital
09/04/20 BTIG
Akebia price target lowered to $6 from $26 at BTIG
09/04/20 Mizuho
Akebia price target lowered to $6 from $17 at Mizuho
DPHC DiamondPeak Holdings
$23.03 /

+ (+0.00%)

09/18/20 Colliers
Lordstown's presentation raised Colliers' expectations for Workhorse valuation
09/17/20 Roth Capital
Roth raises Workhorse target to $33 after Lordstown's 'compelling' analyst day
09/03/20 Oppenheimer
Oppenheimer bullish on Workhorse Group, initiates with an Outperform
08/03/20 Roth Capital
Lordstown's SPAC acquisition driving value for Workhorse, says Roth Capital
JMIA Jumia Technologies
$10.36 /

+ (+0.00%)

08/12/20 RBC Capital
Jumia Technologies price target raised to $15 from $9 at RBC Capital
05/14/20 Stifel
Jumia Technologies downgraded to Hold from Buy at Stifel
03/25/20 Berenberg
Jumia Technologies downgraded to Hold from Buy at Berenberg
02/26/20 RBC Capital
Jumia Technologies price target lowered to $13 from $22 at RBC Capital
LYFT Lyft
$27.81 /

+ (+0.00%)

09/25/20 JPMorgan
Lyft price target lowered to $38 from $41 at JPMorgan
08/28/20 Piper Sandler
Piper 'bearishly inclined' on Uber, Lyft shares into November election
08/24/20 Loop Capital
Uber price target lowered to $40 from $43 at Loop Capital
08/20/20 JPMorgan
Rideshare increasingly likely to shut down in California, says JPMorgan
JKS JinkoSolar
$62.91 /

+ (+0.00%)

09/25/20 Roth Capital
JinkoSolar price target raised to $37 from $29 at Roth Capital
09/24/20 Bocom
JinkoSolar upgraded to Buy from Neutral at Bocom
09/24/20 Credit Suisse
JinkoSolar upgraded to Outperform from Neutral at Credit Suisse
09/21/20 Roth Capital
JinkoSolar price target raised to $29 from $22 at Roth Capital
WKHS Workhorse Group
$26.77 /

+ (+0.00%)

10/09/20 Roth Capital
Roth Capital sees positive outcome for Workhorse in USPS contract
09/03/20
Fly Intel: Top five analyst initiations
LLY Eli Lilly
$156.83 /

+ (+0.00%)

10/08/20 Benchmark
Regeneron antibody data 'more convincing' than Eli Lilly's, says Benchmark
10/07/20 Goldman Sachs
Goldman says Lilly comments support need for multiple COVID-19 antibody makers
10/07/20 Canaccord
Eli Lilly data further validates COVID antibody therapy, says Canaccord
10/01/20 Morgan Stanley
Biogen panel meeting can be 'perception catalyst' for Lilly, says Morgan Stanley
APHA Aphria
$5.75 /

+ (+0.00%)

10/05/20 Cantor Fitzgerald
Aphria price target raised to C$15.50 from C$12.50 at Cantor Fitzgerald
08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
08/18/20 CIBC
Aphria upgraded to Outperformer with 'attractive' 25% upside at CIBC
08/17/20 CIBC
Aphria upgraded to Outperformer from Neutral at CIBC
F Ford
$7.25 /

+ (+0.00%)

10/12/20 Benchmark
Benchmark upgrades Ford to Buy on new management, new products
10/12/20 Benchmark
Ford upgraded to Buy from Hold at Benchmark
09/18/20 Stifel
Fox Factory upgraded to Buy following pullback at Stifel
09/08/20
Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Hot Stocks
Point72 Asset Management reports 6.4% passive stake in Mereo BioPharma » 17:26
03/01/21
03/01
17:26
03/01/21
17:26
MREO

Mereo BioPharma

$3.96 /

+0.07 (+1.80%)

Point72 Asset Management…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

  • 10
    Feb
Hot Stocks
Zoom Video jumps 8% to $444.10 after Q4 results, FY22 guidance beat estimates  17:26
03/01/21
03/01
17:26
03/01/21
17:26
ZM

Zoom Video

$409.67 /

+35.805 (+9.58%)

 
ShowHide Related Items >><<
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

01/26/21 MKM Partners
Fiverr downgraded to Sell from Neutral at MKM Partners
01/13/21 Stifel
Stifel says Zoom growth with Phone reminder of 'powerful' enterprise opportunity
01/13/21 Morgan Stanley
Investors have turned too negative on Zoom's persistence, says Morgan Stanley
12/24/20 DA Davidson
DA Davidson likes Zoom push into email, says buy on recent selloff
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

  • 13
    Jan
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

Hot Stocks
Lockheed Martin awarded $128.68M Navy contract » 17:23
03/01/21
03/01
17:23
03/01/21
17:23
LMT

Lockheed Martin

$333.40 /

+3.4 (+1.03%)

Lockheed Martin was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMT Lockheed Martin
$333.40 /

+3.4 (+1.03%)

LMT Lockheed Martin
$333.40 /

+3.4 (+1.03%)

01/27/21 Credit Suisse
Lockheed Martin price target lowered to $334 from $351 at Credit Suisse
01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
12/22/20 Credit Suisse
Lockheed Martin price target raised to $409 from $400 at Credit Suisse
LMT Lockheed Martin
$333.40 /

+3.4 (+1.03%)

LMT Lockheed Martin
$333.40 /

+3.4 (+1.03%)

LMT Lockheed Martin
$333.40 /

+3.4 (+1.03%)

LMT Lockheed Martin
$333.40 /

+3.4 (+1.03%)

Syndicate
Pyxis Tankers files to sell 14.29M shares of common stock for holders  17:22
03/01/21
03/01
17:22
03/01/21
17:22
PXS

Pyxis Tankers

$1.43 /

+0.15 (+11.72%)

 
ShowHide Related Items >><<
PXS Pyxis Tankers
$1.43 /

+0.15 (+11.72%)

PXS Pyxis Tankers
$1.43 /

+0.15 (+11.72%)

02/17/21 Noble Capital
Pyxis Tankers downgraded to Market Perform from Outperform at Noble Capital
Syndicate
Essential Utilities files automatic mixed securities shelf  17:19
03/01/21
03/01
17:19
03/01/21
17:19
WTRG

Essential Utilities

$42.95 /

+0.9 (+2.14%)

 
ShowHide Related Items >><<
WTRG Essential Utilities
$42.95 /

+0.9 (+2.14%)

WTRG Essential Utilities
$42.95 /

+0.9 (+2.14%)

02/25/21 Wells Fargo
Essential Utilities weakness provides attractive entry point, says Wells Fargo
01/22/21 Barclays
Essential Utilities price target raised to $55 from $50 at Barclays
01/21/21 US Capital Advisors
Essential Utilities initiated with a Hold at US Capital Advisors
01/13/21 Baird
Essential Utilities price target raised to $53 from $46 at Baird
WTRG Essential Utilities
$42.95 /

+0.9 (+2.14%)

  • 11
    Aug
Hot Stocks
Five9 VP Leena Mansharamani sells over $1.2M in shares » 17:17
03/01/21
03/01
17:17
03/01/21
17:17
FIVN

Five9

$197.70 /

+12.52 (+6.76%)

Five9 VP Leena…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FIVN Five9
$197.70 /

+12.52 (+6.76%)

FIVN Five9
$197.70 /

+12.52 (+6.76%)

04:56 Today Jefferies
Five9 initiated with a Buy at Jefferies
02/23/21 Wells Fargo
Five9 price target raised to $210 from $200 at Wells Fargo
02/23/21 Truist
Five9 price target raised to $215 from $165 at Truist
02/23/21 Northland
Five9 price target raised to $200 from $163 at Northland
FIVN Five9
$197.70 /

+12.52 (+6.76%)

FIVN Five9
$197.70 /

+12.52 (+6.76%)

Hot Stocks
Sun Life Financial names Manjit Singh as CFO » 17:16
03/01/21
03/01
17:16
03/01/21
17:16
SLF

Sun Life Financial

$48.71 /

+0.62 (+1.29%)

Sun Life is pleased to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLF Sun Life Financial
$48.71 /

+0.62 (+1.29%)

SLF Sun Life Financial
$48.71 /

+0.62 (+1.29%)

02/12/21 CIBC
Sun Life Financial price target raised to C$69 from C$64 at CIBC
02/12/21 BMO Capital
Sun Life Financial price target raised to C$70 from C$69 at BMO Capital
02/12/21 Canaccord
Sun Life Financial price target raised to C$69 from C$68.50 at Canaccord
02/12/21 Credit Suisse
Sun Life Financial price target raised to C$67 from C$65 at Credit Suisse
SLF Sun Life Financial
$48.71 /

+0.62 (+1.29%)

Syndicate
Atara Biotherapeutics files to sell $79.65M of common stock » 17:10
03/01/21
03/01
17:10
03/01/21
17:10
ATRA

Atara Biotherapeutics

$17.07 /

+0.305 (+1.82%)

Cowen and Company is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATRA Atara Biotherapeutics
$17.07 /

+0.305 (+1.82%)

ATRA Atara Biotherapeutics
$17.07 /

+0.305 (+1.82%)

01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
01/04/21 Roth Capital
Roth keeps Buy rating on Atara as initiation of BLA gets 'slightly' delayed
12/09/20 Citi
Atara Biotherapeutics downgraded to Neutral from Buy at Citi
12/08/20 H.C. Wainwright
Atara Biotherapeutics price target raised to $31 from $28 at H.C. Wainwright
ATRA Atara Biotherapeutics
$17.07 /

+0.305 (+1.82%)

  • 09
    Dec
  • 27
    May
ATRA Atara Biotherapeutics
$17.07 /

+0.305 (+1.82%)

Earnings
Spin Master reports Q4 14c vs. (8c) last year » 17:08
03/01/21
03/01
17:08
03/01/21
17:08
SNMSF

Spin Master

$0.00 /

+ (+0.00%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNMSF Spin Master
$0.00 /

+ (+0.00%)

01/25/21 CIBC
Spin Master price target lowered to C$33 from C$35 at CIBC
12/10/20 CIBC
Spin Master upgraded to Outperformer from Neutral at CIBC
11/16/20 BMO Capital
Spin Master price target raised to C$28 from C$25 at BMO Capital
11/13/20 Scotiabank
Spin Master price target raised to C$31 from C$29.50 at Scotiabank
Syndicate
Atara Biotherapeutics files automatic mixed securities shelf  17:07
03/01/21
03/01
17:07
03/01/21
17:07
ATRA

Atara Biotherapeutics

$17.07 /

+0.305 (+1.82%)

 
ShowHide Related Items >><<
ATRA Atara Biotherapeutics
$17.07 /

+0.305 (+1.82%)

ATRA Atara Biotherapeutics
$17.07 /

+0.305 (+1.82%)

01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
01/04/21 Roth Capital
Roth keeps Buy rating on Atara as initiation of BLA gets 'slightly' delayed
12/09/20 Citi
Atara Biotherapeutics downgraded to Neutral from Buy at Citi
12/08/20 H.C. Wainwright
Atara Biotherapeutics price target raised to $31 from $28 at H.C. Wainwright
ATRA Atara Biotherapeutics
$17.07 /

+0.305 (+1.82%)

  • 09
    Dec
  • 27
    May
ATRA Atara Biotherapeutics
$17.07 /

+0.305 (+1.82%)

Earnings
NIO sees Q1 revenue $1.13B-$1.16B, consensus $718.49M » 17:04
03/01/21
03/01
17:04
03/01/21
17:04
NIO

NIO

$49.79 /

+3.08 (+6.59%)

In Q1, deliveries of the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

02/26/21 HSBC
NIO price target raised to $54 from $44.70 at HSBC
02/09/21 Deutsche Bank
NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
01/28/21 Morgan Stanley
NIO price target raised to $80 from $33 at Morgan Stanley
01/22/21
Fly Intel: Top five analyst initiations
NIO NIO
$49.79 /

+3.08 (+6.59%)

  • 14
    Dec
  • 31
    Aug
  • 11
    Jun
NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

Syndicate
Morgan Stanley files to sell 2.32M shares of common stock for holders  17:04
03/01/21
03/01
17:04
03/01/21
17:04
MS

Morgan Stanley

$79.17 /

+2.295 (+2.99%)

 
ShowHide Related Items >><<
MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

01/25/21 Credit Suisse
Morgan Stanley price target raised to $84 from $74 at Credit Suisse
01/21/21 DA Davidson
Morgan Stanley price target raised to $90 from $80 at DA Davidson
01/21/21 Barclays
Morgan Stanley price target raised to $95 from $88 at Barclays
01/21/21 RBC Capital
Morgan Stanley price target raised to $78 from $55 at RBC Capital
MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

Hot Stocks
Macy's eliminates COO role, appoints Laura Miller as Chief Information Officer » 17:03
03/01/21
03/01
17:03
03/01/21
17:03
M

Macy's

$15.32 /

+0.12 (+0.79%)

Macy's announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
M Macy's
$15.32 /

+0.12 (+0.79%)

M Macy's
$15.32 /

+0.12 (+0.79%)

02/24/21 Credit Suisse
Macy's price target raised to $13 from $7 at Credit Suisse
02/24/21 Deutsche Bank
Macy's price target raised to $16 from $15 at Deutsche Bank
02/18/21 Morgan Stanley
Macy's price target raised to $11 from $6 at Morgan Stanley
01/21/21 Deutsche Bank
Macy's price target raised to $15 from $9 at Deutsche Bank
M Macy's
$15.32 /

+0.12 (+0.79%)

M Macy's
$15.32 /

+0.12 (+0.79%)

M Macy's
$15.32 /

+0.12 (+0.79%)

M Macy's
$15.32 /

+0.12 (+0.79%)

Hot Stocks
TriCo Bancshares announces buyback for up to 2M shares of common stock » 17:02
03/01/21
03/01
17:02
03/01/21
17:02
TCBK

TriCo Bancshares

$44.39 /

+1.06 (+2.45%)

TriCo Bancshares approved…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCBK TriCo Bancshares
$44.39 /

+1.06 (+2.45%)

TCBK TriCo Bancshares
$44.39 /

+1.06 (+2.45%)

10/28/20 Stephens
TriCo Bancshares resumed with an Equal Weight at Stephens
TCBK TriCo Bancshares
$44.39 /

+1.06 (+2.45%)

Earnings
NIO reports Q4 adjusted EPS (14c), consensus (7c) » 17:02
03/01/21
03/01
17:02
03/01/21
17:02
NIO

NIO

$49.79 /

+3.08 (+6.59%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

02/26/21 HSBC
NIO price target raised to $54 from $44.70 at HSBC
02/09/21 Deutsche Bank
NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
01/28/21 Morgan Stanley
NIO price target raised to $80 from $33 at Morgan Stanley
01/22/21
Fly Intel: Top five analyst initiations
NIO NIO
$49.79 /

+3.08 (+6.59%)

  • 14
    Dec
  • 31
    Aug
  • 11
    Jun
NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

Hot Stocks
TriCo Bancshares raises quarterly dividend to 25c from 22c per share » 17:01
03/01/21
03/01
17:01
03/01/21
17:01
TCBK

TriCo Bancshares

$44.39 /

+1.06 (+2.45%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCBK TriCo Bancshares
$44.39 /

+1.06 (+2.45%)

10/28/20 Stephens
TriCo Bancshares resumed with an Equal Weight at Stephens
TCBK TriCo Bancshares
$44.39 /

+1.06 (+2.45%)

Syndicate
NetApp files automatic mixed securities shelf  16:59
03/01/21
03/01
16:59
03/01/21
16:59
NTAP

NetApp

$65.22 /

+2.63 (+4.20%)

 
ShowHide Related Items >><<
NTAP NetApp
$65.22 /

+2.63 (+4.20%)

NTAP NetApp
$65.22 /

+2.63 (+4.20%)

02/26/21 Daiwa
NetApp upgraded to Outperform from Neutral at Daiwa
02/25/21 Wedbush
NetApp price target raised to $70 from $62 at Wedbush
02/25/21 Wells Fargo
NetApp price target raised to $65 from $60 at Wells Fargo
02/25/21 Credit Suisse
NetApp price target raised to $80 from $75 at Credit Suisse
NTAP NetApp
$65.22 /

+2.63 (+4.20%)

NTAP NetApp
$65.22 /

+2.63 (+4.20%)

NTAP NetApp
$65.22 /

+2.63 (+4.20%)

Hot Stocks
Genuine Parts appoints Napoleon Rutledge as chief accounting officer » 16:59
03/01/21
03/01
16:59
03/01/21
16:59
GPC

Genuine Parts

$108.29 /

+2.93 (+2.78%)

Genuine Parts announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPC Genuine Parts
$108.29 /

+2.93 (+2.78%)

GPC Genuine Parts
$108.29 /

+2.93 (+2.78%)

02/18/21 RBC Capital
Genuine Parts price target raised to $104 from $97 at RBC Capital
12/02/20
Fly Intel: Top five analyst downgrades
12/02/20 BofA
Genuine Parts double downgraded to Underperform after doubling at BofA
12/02/20 BofA
Genuine Parts downgraded to Underperform from Buy at BofA
GPC Genuine Parts
$108.29 /

+2.93 (+2.78%)

GPC Genuine Parts
$108.29 /

+2.93 (+2.78%)

Upgrade
Altair upgraded to Neutral from Sell at Goldman Sachs » 16:57
03/01/21
03/01
16:57
03/01/21
16:57
ALTR

Altair

$63.27 /

+1.72 (+2.79%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALTR Altair
$63.27 /

+1.72 (+2.79%)

ALTR Altair
$63.27 /

+1.72 (+2.79%)

02/19/21 RBC Capital
Altair price target raised to $58 from $49 at RBC Capital
12/09/20 JPMorgan
Altair upgraded to Overweight from Neutral at JPMorgan
12/08/20 Benchmark
Altair price target raised to $60 from $53 at Benchmark
11/09/20 RBC Capital
Altair price target raised to $49 from $42 at RBC Capital
ALTR Altair
$63.27 /

+1.72 (+2.79%)

ALTR Altair
$63.27 /

+1.72 (+2.79%)

Syndicate
RedHill Biopharma announces $10M bought deal offering of ADSs » 16:55
03/01/21
03/01
16:55
03/01/21
16:55
RDHL

RedHill Biopharma

$9.19 /

-0.33 (-3.47%)

RedHill Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

11/12/20 Roth Capital
RedHill Biopharma price target lowered to $12 from $16 at Roth Capital
09/11/20 BTIG
RedHill Biopharma initiated with a Buy at BTIG
08/14/20 Roth Capital
Roth Capital maintains Buy on RedHill after 'noisy' quarter
07/07/20 SMBC Nikko
RedHill Biopharma initiated with an Outperform at SMBC Nikko
RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

Syndicate
Yum China files to sell 2.1M shares of common stock  16:53
03/01/21
03/01
16:53
03/01/21
16:53
YUMC

Yum China

$59.87 /

+0.095 (+0.16%)

 
ShowHide Related Items >><<
YUMC Yum China
$59.87 /

+0.095 (+0.16%)

YUMC Yum China
$59.87 /

+0.095 (+0.16%)

01/26/21 Jefferies
Yum China price target raised to $68.70 from $63.10 at Jefferies
11/02/20 Citi
Yum China price target raised to $71.30 from $60.15 at Citi
09/10/20 Goldman Sachs
Yum China H-shares initiated with a Conviction Buy at Goldman Sachs
09/10/20 Goldman Sachs
Yum China H-shares initiated with a Conviction Buy at Goldman Sachs
YUMC Yum China
$59.87 /

+0.095 (+0.16%)

  • 04
    Sep
YUMC Yum China
$59.87 /

+0.095 (+0.16%)

YUMC Yum China
$59.87 /

+0.095 (+0.16%)

Earnings
AppFolio reports Q4 EPS (1c), consensus 7c » 16:52
03/01/21
03/01
16:52
03/01/21
16:52
APPF

AppFolio

$160.72 /

-4.985 (-3.01%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APPF AppFolio
$160.72 /

-4.985 (-3.01%)

APPF AppFolio
$160.72 /

-4.985 (-3.01%)

02/25/21 DA Davidson
AppFolio price target raised to $126 from $110 at DA Davidson
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
10/26/20 Keefe Bruyette
AppFolio initiated with a Market Perform at Keefe Bruyette
APPF AppFolio
$160.72 /

-4.985 (-3.01%)

Earnings
Adverum Biotechnologies reports Q4 EPS (39c), consensus (32c) » 16:50
03/01/21
03/01
16:50
03/01/21
16:50
ADVM

Adverum Biotechnologies

$13.29 /

+0.44 (+3.42%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

12/15/20 UBS
Adverum Biotechnologies initiated with a Neutral at UBS
11/15/20 Piper Sandler
Adverum Biotechnologies shares should grind higher over time, says Piper Sandler
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform at Raymond James
ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

  • 13
    Aug
Hot Stocks
Adverum Biotechnologies provides update on ADVM-022 clinical development path » 16:47
03/01/21
03/01
16:47
03/01/21
16:47
ADVM

Adverum Biotechnologies

$13.29 /

+0.44 (+3.42%)

Adverum Biotechnologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

12/15/20 UBS
Adverum Biotechnologies initiated with a Neutral at UBS
11/15/20 Piper Sandler
Adverum Biotechnologies shares should grind higher over time, says Piper Sandler
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform at Raymond James
ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

  • 13
    Aug
On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:45
03/01/21
03/01
16:45
03/01/21
16:45
JNJ

Johnson & Johnson

$159.34 /

+0.92 (+0.58%)

, XOM

Exxon Mobil

$56.40 /

+2.02 (+3.71%)

, OTRK

Ontrak

$31.62 /

-27.515 (-46.53%)

, ATNX

Athenex

$5.47 /

-6.715 (-55.11%)

, DKNG

DraftKings

$68.71 /

+7.24 (+11.78%)

, MORF

Morphic

$84.57 /

+48.64 (+135.37%)

The three major averages…

ShowHide Related Items >><<
JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

10:21 Today RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
10:17 Today RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

16:38 Today JPMorgan
JPMorgan downgrades Athenex on 'huge surprise' from FDA
16:31 Today SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
16:27 Today JPMorgan
Athenex downgraded to Neutral from Overweight at JPMorgan
13:53 Today Laidlaw
Athenex price target lowered to $13 from $38 at Laidlaw
DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

09:18 Today Craig-Hallum
DraftKings price target raised to $70 from $65 at Craig-Hallum
09:09 Today Canaccord
DraftKings price target raised to $80 from $65 at Canaccord
08:39 Today Northland
DraftKings price target raised to $70 from $55 at Northland
07:05 Today Benchmark
DraftKings price target raised to $69 from $66 at Benchmark
MORF Morphic
$84.57 /

+48.64 (+135.37%)

12:48 Today Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

  • 07
    Oct
  • 10
    Sep
  • 19
    Jun
JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.